Update of clinical trials with edrecolomab: A monoclonal antibody therapy for colorectal cancer

This publication has 9 references indexed in Scilit:

• The biology of the 17–1A antigen (Ep-CAM)
  Journal of Molecular Medicine, 1999
• Monoclonal antibody therapy for resected Dukes' C colorectal cancer: seven-year outcome of a multicenter randomized trial.
  Journal of Clinical Oncology, 1998
• Randomised trial of monoclonal antibody for adjuvant therapy of resected Dukes' C colorectal carcinoma
  The Lancet, 1994
• Induction of Anti-Idiotypic (ab₂) and Anti-Anti-Idiotypic (ab₃) Antibodies in Patients Treated with the Mouse Monoclonal Antibody 17-1A (ab₁). Relation to the Clinical Outcome — An Important Antitumoral Effector Function?
  Hybridoma, 1991
• Cytokine effects and role of adhesive proteins and Fc receptors in human macrophage-mediated antibody dependent cellular cytotoxicity
  Journal of Cellular Biochemistry, 1991
• Levamisole and Fluorouracil for Adjuvant Therapy of Resected Colon Carcinoma
  New England Journal of Medicine, 1990
• The epithelial cell surface antigen 17–1A, a target for antibody‐mediated tumor therapy: Its biochemical nature, tissue distribution and recognition by different monoclonal antibodies
  International Journal of Cancer, 1986
• Binding of murine immunoglobulin to human tissues after immunotherapy with anticolorectal carcinoma monoclonal antibody
  International Journal of Cancer, 1984
• Human Macrophages Armed with Murine Immunoglobulin G2a Antibodies to Tumors Destroy Human Cancer Cells
  Science, 1983